Overview

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University of Missouri-Columbia
Collaborator:
Merck Sharp & Dohme LLC
Treatments:
Bromides
Glycopyrrolate
Neostigmine
Rocuronium